ARCHITECT PROLACTIN 07K76-25

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-08-23 for ARCHITECT PROLACTIN 07K76-25 manufactured by A.i.d.d Longford.

Event Text Entries

[52837184] An evaluation is in process. A follow up report will be submitted when the evaluation is complete. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[52837285] The customer observed a falsely elevated prolactin result on the architect i2000sr analyzer. The following data was provided: initial 55 ng/ml. The sample was sent to a reference lab and the result was 23. 8 ng/ml. The patient underwent a negative mri procedure of her pituitary gland due to the high architect prolactin result. Multiple attempts to get more patient information were unsuccessful.
Patient Sequence No: 1, Text Type: D, B5


[56122979] The complaint trending report review determined that there are no non statistical or adverse trends for the product for the complaint issue. As the likely cause lot number in this case is unknown, testing, lot and device history record reviews could not be performed. To further evaluate the customer's issue, the historical performance in the field of reagent lots using worldwide data through abbottlink was performed. The review showed that although an upward shift in patient median results was observed followed by a downward shift, all within date lots are within +/- 2sd of the mean confirming no systemic issue with any in date lot. Statistical process control chart (spc) analysis was performed for the architect prolactin assay. All lots were within specification and no trends were observed for controls and panels across reagent lots that could potentially be related to the customer's issue. Review of external proficiency (ukneqas) data for the previous 12 months shows all results are within acceptable limits and no performance issues were highlighted for the prolactin assay. The ukneqas macroprolactin survey concluded that identifying patients with apparent hyperprolactinemia attributable to macroprolactin (i. E. High "total" prolactin but normal monomeric prolactin) is desirable to minimise the risk of unnecessary clinical investigation, in particular mri scans. The extent of recognition of macroprolactin depends both on the immunoassay method used and on the nature of the particular macroprolactin present. No method has been shown to lack cross-reactivity with macroprolactin in every case and all methods have been shown to recognise macroprolactin on occasion. A review of the product labeling concluded that the issue is sufficiently addressed, including information that prolactin may exist in alternate structural forms (e. G. , macroprolactin) which may exhibit variable levels of physiological activity. In patients with elevated prolactin results, additional information may be required for diagnosis. Based on all available information the assay performed as intended.
Patient Sequence No: 1, Text Type: N, H10


[78157142] The device evaluation was reassessed and concluded that a malfunction occurred, therefore, the device was not performing as intended at the customer site. However, no systemic issue and/or product deficiency was identified. The conclusion code was changed from (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005094123-2016-00043
MDR Report Key5898822
Date Received2016-08-23
Date of Report2016-09-23
Date of Event2016-06-28
Date Mfgr Received2016-09-18
Date Added to Maude2016-08-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1A.I.D.D LONGFORD
Manufacturer StreetLISNAMUCK CO. LONGFORD
Manufacturer CityLONGFORD NA
Manufacturer CountryEI
Manufacturer Postal CodeNA
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT PROLACTIN
Generic NamePROLACTIN
Product CodeCFT
Date Received2016-08-23
Catalog Number07K76-25
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerA.I.D.D LONGFORD
Manufacturer AddressLISNAMUCK CO. LONGFORD LONGFORD NA EI NA


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-08-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.